94% of Advanced Practice Providers (APPs) believe more educational resources about the rare blood cancer multiple myeloma could help improve the patient experience HORSHAM, Pa., Sept. 26, 2023 ...
A phase 3 trial evaluates the efficacy of mezigdomide plus carfilzomib and dexamethasone vs carfilzomib and dexamethasone in ...
That's My Word™ campaign issues national call to action for earlier diagnosis and treatment to address the disproportionate impact of multiple myeloma among at-risk communities HORSHAM, Pa., March 2, ...
MedPage Today on MSN
Talquetamab regimens boost survival in multiple myeloma
"Combinations represent additional options for early-line treatment," researcher says ...
Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side analysts ...
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial Multiple myeloma (MM) is ...
Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/9203951-janssen-make-it-happen-campaign-supports-apps-caring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results